252 related articles for article (PubMed ID: 28263205)
1. Long-term Follow-up of MEN1 Patients Who Do Not Have Initial Surgery for Small ≤2 cm Nonfunctioning Pancreatic Neuroendocrine Tumors, an AFCE and GTE Study: Association Francophone de Chirurgie Endocrinienne & Groupe d'Etude des Tumeurs Endocrines.
Triponez F; Sadowski SM; Pattou F; Cardot-Bauters C; Mirallié E; Le Bras M; Sebag F; Niccoli P; Deguelte S; Cadiot G; Poncet G; Lifante JC; Borson-Chazot F; Chaffanjon P; Chabre O; Menegaux F; Baudin E; Ruszniewski P; Du Boullay H; Goudet P
Ann Surg; 2018 Jul; 268(1):158-164. PubMed ID: 28263205
[TBL] [Abstract][Full Text] [Related]
2. Metastatic Potential and Survival of Duodenal and Pancreatic Tumors in Multiple Endocrine Neoplasia Type 1: A GTE and AFCE Cohort Study (Groupe d'étude des Tumeurs Endocrines and Association Francophone de Chirurgie Endocrinienne).
Vinault S; Mariet AS; Le Bras M; Mirallié E; Cardot-Bauters C; Pattou F; Ruszniewski P; Sauvanet A; Chanson P; Baudin E; Elias D; Menegaux F; Gaujoux S; Borson-Chazot F; Lifante JC; Caron P; Carrère N; Tabarin A; Laurent C; Klein M; Brunaud L; Niccoli P; Sebag F; Cadiot G; Kianmanesh R; Luu M; Binquet C; Goudet P
Ann Surg; 2020 Dec; 272(6):1094-1101. PubMed ID: 30585820
[TBL] [Abstract][Full Text] [Related]
3. Pancreatoduodenectomy for Neuroendocrine Tumors in Patients with Multiple Endocrine Neoplasia Type 1: An AFCE (Association Francophone de Chirurgie Endocrinienne) and GTE (Groupe d'étude des Tumeurs Endocrines) Study.
Santucci N; Gaujoux S; Binquet C; Reichling C; Lifante JC; Carnaille B; Pattou F; Mirallié E; Facy O; Mathonnet M; Goudet P
World J Surg; 2021 Jun; 45(6):1794-1802. PubMed ID: 33649917
[TBL] [Abstract][Full Text] [Related]
4. French guidelines from the GTE, AFCE and ENDOCAN-RENATEN (Groupe d'étude des Tumeurs Endocrines/Association Francophone de Chirurgie Endocrinienne/Reseau national de prise en charge des tumeurs endocrines) for the screening, diagnosis and management of Multiple Endocrine Neoplasia Type 1.
Goudet P; Cadiot G; Barlier A; Baudin E; Borson-Chazot F; Brunaud L; Caiazzo R; Cardot-Bauters C; Castinetti F; Chanson P; Cuny T; Dansin E; Gaujoux S; Giraud S; Groussin L; Le Bras M; Lifante JC; Mathonnet M; de Mestier L; Mirallié E; Pattou F; Romanet P; Sebag F; Tresallet C; Vezzosi D; Walter T; Tabarin A
Ann Endocrinol (Paris); 2024 Feb; 85(1):2-19. PubMed ID: 37739121
[No Abstract] [Full Text] [Related]
5. Risk factors and causes of death in MEN1 disease. A GTE (Groupe d'Etude des Tumeurs Endocrines) cohort study among 758 patients.
Goudet P; Murat A; Binquet C; Cardot-Bauters C; Costa A; Ruszniewski P; Niccoli P; Ménégaux F; Chabrier G; Borson-Chazot F; Tabarin A; Bouchard P; Delemer B; Beckers A; Bonithon-Kopp C
World J Surg; 2010 Feb; 34(2):249-55. PubMed ID: 19949948
[TBL] [Abstract][Full Text] [Related]
6. One-Year Postoperative Mortality in MEN1 Patients Operated on Gastric and Duodenopancreatic Neuroendocrine Tumors: An AFCE and GTE Cohort Study.
Christou N; Mathonnet M; Gaujoux S; Cadiot G; Deguelte S; Kraimps JL; Lifante JC; Menegaux F; Mirallié E; Muscari F; Carnaille B; Pattou F; Sauvanet A; Goudet P
World J Surg; 2019 Nov; 43(11):2856-2864. PubMed ID: 31384998
[TBL] [Abstract][Full Text] [Related]
7. Is surgery beneficial for MEN1 patients with small (< or = 2 cm), nonfunctioning pancreaticoduodenal endocrine tumor? An analysis of 65 patients from the GTE.
Triponez F; Goudet P; Dosseh D; Cougard P; Bauters C; Murat A; Cadiot G; Niccoli-Sire P; Calender A; Proye CA;
World J Surg; 2006 May; 30(5):654-62; discussion 663-4. PubMed ID: 16680582
[TBL] [Abstract][Full Text] [Related]
8. Prospective endoscopic ultrasonographic evaluation of the frequency of nonfunctioning pancreaticoduodenal endocrine tumors in patients with multiple endocrine neoplasia type 1.
Thomas-Marques L; Murat A; Delemer B; Penfornis A; Cardot-Bauters C; Baudin E; Niccoli-Sire P; Levoir D; Choplin Hdu B; Chabre O; Jovenin N; Cadiot G;
Am J Gastroenterol; 2006 Feb; 101(2):266-73. PubMed ID: 16454829
[TBL] [Abstract][Full Text] [Related]
9. Penetrance of functioning and nonfunctioning pancreatic neuroendocrine tumors in multiple endocrine neoplasia type 1 in the second decade of life.
Gonçalves TD; Toledo RA; Sekiya T; Matuguma SE; Maluf Filho F; Rocha MS; Siqueira SA; Glezer A; Bronstein MD; Pereira MA; Jureidini R; Bacchella T; Machado MC; Toledo SP; Lourenço DM
J Clin Endocrinol Metab; 2014 Jan; 99(1):E89-96. PubMed ID: 24178797
[TBL] [Abstract][Full Text] [Related]
10. Histologically Proven Bronchial Neuroendocrine Tumors in MEN1: A GTE 51-Case Cohort Study.
Lecomte P; Binquet C; Le Bras M; Tabarin A; Cardot-Bauters C; Borson-Chazot F; Lombard-Bohas C; Baudin E; Delemer B; Klein M; Vergès B; Aparicio T; Cosson E; Beckers A; Caron P; Chabre O; Chanson P; Du Boullay H; Guilhem I; Niccoli P; Rohmer V; Guigay J; Vulpoi C; Scoazec JY; Goudet P
World J Surg; 2018 Jan; 42(1):143-152. PubMed ID: 28785839
[TBL] [Abstract][Full Text] [Related]
11. Early and Late Complications After Surgery for MEN1-related Nonfunctioning Pancreatic Neuroendocrine Tumors.
Nell S; Borel Rinkes IHM; Verkooijen HM; Bonsing BA; van Eijck CH; van Goor H; de Kleine RHJ; Kazemier G; Nieveen van Dijkum EJ; Dejong CHC; Valk GD; Vriens MR;
Ann Surg; 2018 Feb; 267(2):352-356. PubMed ID: 27811505
[TBL] [Abstract][Full Text] [Related]
12. Management of pancreatic endocrine tumors in multiple endocrine neoplasia type 1.
Kouvaraki MA; Shapiro SE; Cote GJ; Lee JE; Yao JC; Waguespack SG; Gagel RF; Evans DB; Perrier ND
World J Surg; 2006 May; 30(5):643-53. PubMed ID: 16680581
[TBL] [Abstract][Full Text] [Related]
13. Higher risk of death among MEN1 patients with mutations in the JunD interacting domain: a Groupe d'etude des Tumeurs Endocrines (GTE) cohort study.
Thevenon J; Bourredjem A; Faivre L; Cardot-Bauters C; Calender A; Murat A; Giraud S; Niccoli P; Odou MF; Borson-Chazot F; Barlier A; Lombard-Bohas C; Clauser E; Tabarin A; Parfait B; Chabre O; Castermans E; Beckers A; Ruszniewski P; Le Bras M; Delemer B; Bouchard P; Guilhem I; Rohmer V; Goichot B; Caron P; Baudin E; Chanson P; Groussin L; Du Boullay H; Weryha G; Lecomte P; Penfornis A; Bihan H; Archambeaud F; Kerlan V; Duron F; Kuhn JM; Vergès B; Rodier M; Renard M; Sadoul JL; Binquet C; Goudet P
Hum Mol Genet; 2013 May; 22(10):1940-8. PubMed ID: 23376981
[TBL] [Abstract][Full Text] [Related]
14. MEN1 disease occurring before 21 years old: a 160-patient cohort study from the Groupe d'étude des Tumeurs Endocrines.
Goudet P; Dalac A; Le Bras M; Cardot-Bauters C; Niccoli P; Lévy-Bohbot N; du Boullay H; Bertagna X; Ruszniewski P; Borson-Chazot F; Vergès B; Sadoul JL; Ménégaux F; Tabarin A; Kühn JM; d'Anella P; Chabre O; Christin-Maitre S; Cadiot G; Binquet C; Delemer B
J Clin Endocrinol Metab; 2015 Apr; 100(4):1568-77. PubMed ID: 25594862
[TBL] [Abstract][Full Text] [Related]
15. Causes of death and prognostic factors in multiple endocrine neoplasia type 1: a prospective study: comparison of 106 MEN1/Zollinger-Ellison syndrome patients with 1613 literature MEN1 patients with or without pancreatic endocrine tumors.
Ito T; Igarashi H; Uehara H; Berna MJ; Jensen RT
Medicine (Baltimore); 2013 May; 92(3):135-181. PubMed ID: 23645327
[TBL] [Abstract][Full Text] [Related]
16. Comparison of surgical results in patients with advanced and limited disease with multiple endocrine neoplasia type 1 and Zollinger-Ellison syndrome.
Norton JA; Alexander HR; Fraker DL; Venzon DJ; Gibril F; Jensen RT
Ann Surg; 2001 Oct; 234(4):495-505; discussion 505-6. PubMed ID: 11573043
[TBL] [Abstract][Full Text] [Related]
17. Unraveling the intrafamilial correlations and heritability of tumor types in MEN1: a Groupe d'étude des Tumeurs Endocrines study.
Thevenon J; Bourredjem A; Faivre L; Cardot-Bauters C; Calender A; Le Bras M; Giraud S; Niccoli P; Odou MF; Borson-Chazot F; Barlier A; Lombard-Bohas C; Clauser E; Tabarin A; Pasmant E; Chabre O; Castermans E; Ruszniewski P; Bertherat J; Delemer B; Christin-Maitre S; Beckers A; Guilhem I; Rohmer V; Goichot B; Caron P; Baudin E; Chanson P; Groussin L; Du Boullay H; Weryha G; Lecomte P; Schillo F; Bihan H; Archambeaud F; Kerlan V; Bourcigaux N; Kuhn JM; Vergès B; Rodier M; Renard M; Sadoul JL; Binquet C; Goudet P
Eur J Endocrinol; 2015 Dec; 173(6):819-26. PubMed ID: 26392472
[TBL] [Abstract][Full Text] [Related]
18. Gender-related differences in MEN1 lesion occurrence and diagnosis: a cohort study of 734 cases from the Groupe d'etude des Tumeurs Endocrines.
Goudet P; Bonithon-Kopp C; Murat A; Ruszniewski P; Niccoli P; Ménégaux F; Chabrier G; Borson-Chazot F; Tabarin A; Bouchard P; Cadiot G; Beckers A; Guilhem I; Chabre O; Caron P; Du Boullay H; Verges B; Cardot-Bauters C
Eur J Endocrinol; 2011 Jul; 165(1):97-105. PubMed ID: 21551167
[TBL] [Abstract][Full Text] [Related]
19. What is the appropriate management of nonfunctioning pancreatic neuroendocrine tumours disclosed on screening in adult patients with multiple endocrine neoplasia type 1?
Challis BG; Casey RT; Grossman A; Newell-Price J; Newey P; Thakker RV
Clin Endocrinol (Oxf); 2019 Dec; 91(6):708-715. PubMed ID: 31505044
[TBL] [Abstract][Full Text] [Related]
20. Long-term results of the surgical management of insulinoma patients with MEN1: a Groupe d'étude des Tumeurs Endocrines (GTE) retrospective study.
Vezzosi D; Cardot-Bauters C; Bouscaren N; Lebras M; Bertholon-Grégoire M; Niccoli P; Levy-Bohbot N; Groussin L; Bouchard P; Tabarin A; Chanson P; Lecomte P; Guilhem I; Carrere N; Mirallié E; Pattou F; Peix JL; Goere D; Borson-Chazot F; Caron P; Bongard V; Carnaille B; Goudet P; Baudin E
Eur J Endocrinol; 2015 Mar; 172(3):309-19. PubMed ID: 25538206
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]